Inhibikase Therapeutics, Inc. (Nasdaq: IKT) stock gained on Wednesday despite another bearish day in the broader markets, moving higher by about 3% and, at press time, adding another 5% to that increase. The bullish sentiment makes sense even in the face of market turmoils. IKT scored massively positive news from the FDA when it announced […]
